Nebulizers Market is expected to reach US$ 1315.57 Million by 2031

Rising Incidence of Chronic Respiratory Diseases Fuel Nebulizers Market Growth

According to our latest study, “Nebulizers Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis – by Type, Application, End User, and Geography," the market was valued at US$ 855.4 million in 2024 and is expected to reach US$ 1315.57 million by 2031; it is estimated to record a CAGR of 6.5% during 2025–2031. The report includes prospects owing to the current nebulizers market trends and their foreseeable impact during the forecast period.

The rising incidence of chronic respiratory diseases drives the nebulizers market growth. Chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis require successful management. Nebulizers are critical administration devices to deliver medications directly into the lungs. The World Health Organization very conservatively estimates that asthma affects nearly 235 million people worldwide, while COPD is the third most common cause of death worldwide. In September 2024, the Centers for Disease Control and Prevention (CDC) estimated that smoking and secondhand smoke were responsible for ~500,000 deaths annually in the US.

Nebulizers Market

The rising incidence of these chronic respiratory diseases can be attributed to various factors, including environmental pollution, smoking, genetic predispositions, and changing lifestyles. Urban air pollution and increased tobacco consumption have been linked to higher rates of respiratory conditions, leading to an increased demand for nebulizers as a treatment option.

Omron Healthcare Inc.; Koninklijke Philips NV; PARI Respiratory Equipment, Inc; Drive Devilbiss Healthcare Ltd; GF Health Products Inc; Trudell Medical International; Besco Medical Ltd; Medline Industries LP; Teleflex Inc and Bremed Ltd are among the key players profiled in the nebulizers market report. Other players were also studied and analyzed during the market study to get a holistic view of the market and its ecosystem. 

The report includes the nebulizers market forecast by type, application, and end user. Based on type, the global nebulizers market is segmented into jet nebulizers, ultrasonic nebulizers, and mesh nebulizers. Mesh nebulizers are the most modern segment of the nebulizers market, as they make use of vibrating mesh technology to form a very fine aerosol mist from liquid medicine. The technology draws from aspects of ultrasonic and jet nebulizers while finding solutions to many of the limitations designed and developed by both styles of nebulizers. Mesh nebulizers are compact, lightweight, nearly silent in device operation, and have high efficiency in drug delivery with very little medication. Mesh nebulizers are effective in treating patients who need to use inhaled medications frequently or for a prolonged period such as patients with asthma, COPD, and chronic respiratory illnesses. The mesh nebulizer easily adds to the portable and streamlined experience that allows individuals to treat themselves for medications at home or on the move. This segment held the largest nebulizers market share in 2024.

The scope of the nebulizers market report focuses on North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Asia Pacific dominated the market in 2024, followed by North America and Europe.

The nebulizers market in Asia Pacific is segmented into Australia, China, Japan, India, South Korea, and the Rest of the Asia Pacific. India held the largest nebulizers market share in APAC. The nebulizer market in China is expanding, supported by the vast population and the burden of respiratory diseases. With a growing elderly population, respiratory support for older adults will be an increasing burden. Urbanization, together with pollution, is causing detrimental effects on respiratory health. Relevant government policies continue to provide access to healthcare. Nebulizer advances include having more nimble, efficient and user-friendly options, based on data that they are more likely to provide better compliance and outcomes. In 2024, the NMPA approved 48 new innovative drugs and 65 new medical devices relating to nebulizers, demonstrating the ongoing support for healthcare.

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com